Cubist Pharmaceuticals The Shape Of Cures To Come.™
  • About Cubist
  • Products & Pipeline
  • Investor Relations
  • Careers
  • News & Media
  • Search
  • News & Media
  • Cubist in the News
  • Press Releases
  • Background Materials

Upcoming Events

  • 28 Feb
    2012 RBC Capital Markets’ Global Healthcare Conference
    Tuesday Feb. 28th 2012
  • 22 Mar
    Pharm Country Career Fair
    Thursday Mar. 22nd 2012
  • 7 Jun
    Cubist Pharmaceuticals Annual Meeting of Stockholders
    Thursday Jun. 7th 2012
  • View All Upcoming Events

News & Media

Superbugs - The threat is real.

Press Releases View All

  • 2/20/2012
    Cubist Pharmaceuticals to Present at February/March Investor Conferences
  • 2/16/2012
    Cubist Pharmaceuticals Appoints Alison Lawton to Board of Directors
  • 2/9/2012
    Cubist Receives CUBICIN Paragraph IV Notice Letter
  • 1/19/2012
    Cubist Pharmaceuticals Reports 2011 Fourth Quarter and Full Year Financial Results
  • 1/10/2012
    Cubist Pharmaceuticals and Hydra Biosciences Announce Plans to Begin Phase 1 Clinical Trial for Novel TRPA1 Modulator to Treat Acute Pain
  • 1/9/2012
    Cubist Announces Full Year 2011 Total CUBICIN Net Product Revenues of $735.5 Million, Up 18% Over 2010
  • 1/4/2012
    Cubist Pharmaceuticals and The New England Patriots Radio Network Honor Merrimack, New Hampshire, Science Teacher
  • 12/13/2011
    Cubist Announces First Patient Dosed in Pivotal Global Phase 3 Trial of CXA-201 for Complicated Intra-Abdominal Infections
  • 12/12/2011
    Cubist Pharmaceuticals Completes Acquisition of Adolor Corporation
  • 12/7/2011
    Cubist Pharmaceuticals Announces Results of Initial Tender Offer for Outstanding Shares of Adolor Corporation and Commencement of Subsequent Offering Period

Cubist in the News View All

  • Nothing bugs Cubist CEO Michael Bonney View
    Loyalty, commitment and a cool head saves a money-making drug
  • Cubist-sponsored Battling Superbugs micro site launched View

Media Contact

At Cubist:

Francis McLoughlin
Director, Corporate Communications
(781) 860-8777
francis.mcloughlin@cubist.com

65 Hayden Avenue p. 781.860.8660 Lexington, MA 02421
  • Home
  • About
    Cubist
  • Products &
    Pipeline
  • Investor
    Relations
  • Careers
  • News &
    Media
  • Search
  • Privacy
    Policy